Clinical pharmacological test of calcium alginate capsules -Optimization study of postprandial serum triglyceride elevation suppression effect (additional preliminary study)- - Optimization test of postprandial serum triglyceride elevation suppression effect of calcium alginate capsules (additional preliminary study).

Takasaki University of Health and Welfare0 个研究点目标入组 9 人开始时间: 2023年10月20日最近更新: 2024年9月2日

适应症

试验速览

暂无简介。

•Persons receiving treatment, medication, or lifestyle guidance from a doctor due to dyslipidemia or diabetes. People who regularly use medicines, health foods, or supplements that affect blood lipids. Persons who have some kind of disease and are receiving medication and are deemed unsuitable as subjects by the research doctor. Persons who may have allergic symptoms related to rubber or latex. Persons who may develop allergic symptoms regarding fat-loaded foods (corn oil, etc.). Persons whose HIV antigen/antibody, HBs antigen, HCV antibody, or syphilis test result was positive at the time of screening. Persons with obvious abnormalities found in hematological or biochemical tests. Those who are pregnant, wish to become pregnant during the test, or are breastfeeding. Persons whose TG delta C3h (estimated TGCmax) is less than 30 mg/dL in the screening test. Those who have been diagnosed with bronchial asthma and are receiving treatment, or those who have received treatment in the past.

发起方